A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.
Open Access
- 1 July 1985
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 48 (7) , 639-644
- https://doi.org/10.1136/jnnp.48.7.639
Abstract
One hundred and eighty one patients with previously untreated epilepsy were randomised to sodium valproate, phenytoin or carbamazepine as monotherapy and followed up for a median period which ranged from 14 to 24 months. All three drugs were highly effective in the control of generalised seizures but less effective for partial seizures. Excellent or good control was achieved with therapeutic levels of sodium valproate and carbamazepine, but with subtherapeutic levels of phenytoin.Keywords
This publication has 19 references indexed in Scilit:
- Unnecessary polypharmacy in patients with frequent seizuresActa Neurologica Scandinavica, 1984
- Sodium Valproate: Monotherapy and PolytherapyEpilepsia, 1982
- Side Effects of Sodium Valproate in Monotherapy Controlled by Plasma Levels: A Study in 88 Pediatric PatientsEpilepsia, 1982
- Comparison of Sodium Valproate and Phenytoin as Single Drug Treatment in EpilepsyEpilepsia, 1981
- Monotherapy or Poly therapy for Epilepsy?Epilepsia, 1981
- Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- One drug for epilepsy.BMJ, 1978
- A Comparative Controlled Study Between Carbamazepine and Diphenylhydantoin in Psychomotor EpilepsyEpilepsia, 1976
- ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSYThe Lancet, 1976
- Sodium Valproate in Treatment of EpilepsyBMJ, 1974